23 March 2011
Left ventricular assist device as ‘bridge to weight loss’ prior to transplantation in obese patients with advanced heart failurePavittarpaul DhesiABCDEF, Sinan A. SimsirAE, Daniel DaneshvarBC, Asim RafiqueBC, Anita PhanADEF, Ernst R. SchwarzADEF
Ann Transplant 2011; 16(1): 5-13 :: ID: 881632
Background: Obesity is a risk factor for heart failure (HF) and associated with poor outcomes after cardiac transplantation.
We assessed change in total body weight, morbidity and mortality in obese heart failure patients after implantation of a left ventricular assist device (LVAD) compared to medical management.
Material/Methods: Nineteen patients (9 females, age 51.3±10 years) with a body mass index (BMI) ≥30.0 kg/m2 and advanced HF (NYHA class III–IV, stage D) were evaluated. Thirteen (group 1) received insertion of a LVAD as bridge to transplantation. The remaining patients (group 2) were medically managed. All were advised on lifestyle modification.
Results: At baseline, group 1 (49.1±10.7 years) had a total body weight (BW) of 246.6±34.9 pounds (mean ±SD) and a BMI of 36.1±4 kg/m2. Group 2 (56±6.7 yrs) had a BW of 238.8±73.6 pounds and a BMI of 39.1±9.3 kg/m2 (n.s. compared to group 1). All patients were alive at 12 months. At 6 months, BW in group 1 was reduced to 216.3±20.8 pounds, and BMI to 31.8±3.3 kg/m2 (p<0.05). At 6 months, BW in group 2 was 238.2±84.6 pounds, and BMI was 39.1±11.6 kg/m2 (n.s. vs. baseline, p<0.05 compared to group 1). The decrease in BW in group 1 was 12.3±12% (30.3±28.5 pounds). There was no change in BW in group 2 (0.3±8.7%, 0.6±21 pounds, p<0.05 vs. group 1). At 12 months, 7 patients in group 1 (54%) underwent cardiac transplantation.
Conclusions: LVAD insertion resulted in weight loss in obese patients not considered for heart transplantation compared to medically managed patients.
Keywords: left ventricular assist device, Heart Failure, obesity, Weight Loss, cardiac transplantation
20 Jan 2022 : Original articleImpact on Waitlist Outcomes from Changes in the Medical Eligibility of Candidates for Simultaneous Liver-Ki...
Ann Transplant In Press; DOI: 10.12659/AOT.934850
19 Jan 2022 : Original articleCarbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in He...
Ann Transplant In Press; DOI: 10.12659/AOT.933420
18 Jan 2022 : Original articlePLGA+Fe₃O₄+PFP Nanoparticles Drug-Delivery Demonstrates Potential Anti-Tumor Effects on Tumor Cells
Ann Transplant In Press; DOI: 10.12659/AOT.933246
Most Viewed Current Articles
29 Dec 2021 : Original articleEfficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...
Ann Transplant 2021; 26:e933588
22 Dec 2021 : Original articleComparison of Coronary Artery Calcium Scoring with Dobutamine Stress Echo for Detection of Coronary Artery ...
Ann Transplant 2021; 26:e934163
12 Jan 2022 : Original articleRisk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...
Ann Transplant 2022; 27:e934738